In January 2023, the FDA announced that CBD products will require a new regulatory pathway per the USDA, and will work with Congress to develop a strategy. CBD products will no longer be categorized as dietary supplements or food additives. The announcement cites risk management concerns that stem from emerging research on the side effects of CBD on the liver when mixed with other medications, the male reproductive system’s function, and exposure to children and pregnant women. However, it’s important to note that no official statements have yet been released regarding any of these hypotheses. Research studies on dosage vs. effect are still underway and therefore remain currently inconclusive.

Although (as of February 2023) no federal law can officially claim the legal status of CBD, CBD products are still required to be regulated by the FDA.

In the future, new regulatory protocols might include stricter rules for labeling, content limits, minimum purchase age, and oversight around CBD for animals. Solutions may also include implementing multiple routes for product approval to adjust to the spectrum of CBD products being manufactured in order to meet consumer needs while being mindful of protecting public health.

For recent updates on 2023 CBD legislation per state, check out this state-by-state review published by Forbes in January. In summary, here are the states that have or intend to legalize CBD this year.

Legalizing CBD opens all kinds of doors that have the potential to greatly contribute to the advancement of our society.

Here are some of the ways researchers project legalizing CBD can benefit us, both as individuals and as a collective:

According to Extrapolate’s latest research report, the global CBD market is set to hit a 15.3% CAGR (compound annual growth rate) by 2032, with a projected market rate of $25.15 billion. However, current legal restrictions play a huge role in how these measures will actually play out. The next steps in moving the needle forward entail not only legalization but social acceptance as well.

As a leading women’s wellness brand that recognizes CBD’s powerful healing potential, Ladykind wholeheartedly advocates for the federal legalization of CBD, and hopes you will too. Our mission not only speaks to helping women find relief from the painful symptoms of PMS and menopause through our product offerings, but also to eliminating the stigma and normalizing social discourse about culturally taboo topics (like periods and the female reproductive system) through content such as this article.

Visit our CBD Academy and read our blog to learn more about Ladykind’s advocacy for CBD.